Sun Pharmaceuticals Industries Ltd Share Price Sun Pharma.Inds.

401.35

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

401.40

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

403.45

Open ()
Open Interest
(Contracts)
VWAP ()
Day's Vol
(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 26-Sep-2018 21-Aug-2018 - -
AGM 26/09/2018 This is to inform you that the 26th Annual General Meeting of the shareholders of the Company would be held on Wednesday, September 26, 2018 at 02:45 p.m. at Crystal Hall, Grand Mercure Vadodara Surya Palace, Opposite Parsi Agyari, Sayajigunj, Vadodara - 390 020, Gujarat. Further, in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Register of Members and Share Transfer Books of the Company will be closed from Wednesday, September 19, 2018 to Wednesday, September 26, 2018 (both days inclusive) for the purpose of holding of the 26th Annual General Meeting of the Company and declaration and payment of dividend. Dividend shall be paid to the equity shareholders of the Company whose name stand in the register of members as beneficial owners at the close of the business as on Tuesday, September 18, 2018, as per the list provided by NSDL & CDSL in respect of shares held in electronic form and as members in the register of members of the Company after giving effect to valid transfers in physical form lodged with the Company on or before Tuesday, September 18, 2018. The payment of Dividend shall be made on or before 1st October, 2018. This is for your information and records. (As Per BSE Announcement Dated On 20/08/2018) Pursuant to Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, we are enclosing herewith Notice for the 26th Annual General Meeting of the shareholders of the Company, scheduled to be held on Wednesday, September 26, 2018 at 02.45 p.m. at Crystal Hall, Grand Mercure Vadodara Surya Palace, Opposite Parsi Agyari, Sayajigunj, Vadodara - 390 020, Gujarat, India, (a copy of which is being despatched/emailed to all the shareholders of the Company). The business proposed to be transacted at the 26th Annual General Meeting, as detailed in the Notice, are as follows: ORDINARY BUSINESS: 1. a. Adoption of audited standalone financial statements of the Company for the financial year ended March 31, 2018 and the reports of the Board of Directors and Auditors thereon b. Adoption of audited consolidated financial statements of the Company for the financial year ended March 31, 2018 and the report of the Auditors thereon 2. Declaration of dividend on equity shares for the financial year ended March 31, 2018 3. Re-appointment of Mr. Dilip S. Shanghvi (DIN: 00005588), who retires by rotation and being eligible offers himself for re-appointment 4. Re-appointment of Mr. Sudhir V. Valia (DIN: 00005561), who retires by rotation and being eligible offers himself for re-appointment SPECIAL BUSINESS: 5. Appointment of Mr. Vivek Chaand Sehgal (DIN: 00291126) as Independent Director of the Company 6. Appointment of Mr. Gautam Doshi (DIN: 00004612) as an Independent Director of the Company 7. Special Resolution for re-appointment and remuneration of Mr. Sudhir V. Valia (DIN: 00005561) as Whole-time Director 8. Special Resolution for re-appointment and remuneration of Mr. Sailesh T. Desai (DIN: 00005443) as Whole-time Director 9. Re-appointment of Mr. Kalyanasundaram Subramanian (DIN: 00179072) as Whole-time Director without any remuneration 10. Special Resolution for continuation of Directorship of Mr. Israel Makov (DIN:05299764) 11. Ratification of Remuneration of Cost Auditors of the Company for the financial year 2018-19 This is for your information and record. (As Per BSE Announcement Dated on 31.08.2018) Submission of Newspaper advertisement regarding i) Notice of the 26th Annual General Meeting of the Company to be held on Wednesday, September 26, 2018 for the financial year 2017-18, ii) E-voting and iii) Book Closure, in all the editions of Financial Express dated September 05, 2018 and in Ahmedabad Edition (Gujarati Language) of Financial Express dated September 05, 2018. (As Per BSE Announcement Dated on 05.09.2018) Proceedings of 26th Annual General Meeting of Sun Pharmaceutical Industries Limited held on September 26, 2018 and intimation of Change in Directors of the Company pursuant to Clause 13 and 7 of Para A of Part A of Schedule III of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) respectively. (As Per BSE Announcement Dated on 26.09.2018) Text of the speech delivered by chairman at the 26th Annual General Meeting of Sun Pharmaceutical Industries Ltd., held on September 26, 2018 Submission of Voting Results of Twenty Sixth Annual General Meeting of the Company held on September 26, 2018 in accordance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizers Report. (As Per BSE Announcement Dated On 27/09/2018) Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 28.09.2018)